Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Globus Medical
GMED
$11.3B
| $910K | 0.01% |
21,522
-74,370
| -78% | -$3.23M |
|
|
SP
652
DELISTED
SP Plus Corporation
SP
| $909K | 0.01% |
28,474
-3,312
| -10% | -$109K |
|
653
Morgan Stanley
MS
$338B
| $906K | 0.01% |
20,674
+9,017
| +77% | +$402K |
|
|
AVLR
654
DELISTED
Avalara, Inc.
AVLR
| $906K | 0.01% |
+12,547
| New | +$810K |
|
|
AVP
655
DELISTED
Avon Products, Inc.
AVP
| $896K | 0.01% |
230,802
-168,300
| -42% | -$561K |
|
656
Veracyte
VCYT
$3.3B
| $890K | 0.01% |
+31,232
| New | +$780K |
|
657
Interparfums
IPAR
$3.72B
| $887K | 0.01% |
13,340
+3,849
| +41% | +$269K |
|
658
Neurocrine Biosciences
NBIX
$15.6B
| $887K | 0.01% |
10,504
-8,828
| -46% | -$725K |
|
|
WP
659
DELISTED
Worldpay, Inc.
WP
| $884K | 0.01% |
7,217
+829
| +13% | +$98.3K |
|
660
Enpro
NPO
$6.47B
| $881K | 0.01% |
13,794
-6,042
| -30% | -$395K |
|
661
Keurig Dr Pepper
KDP
$44.2B
| $875K | 0.01% |
+30,266
| New | +$862K |
|
662
Abbott
ABT
$202B
| $869K | 0.01% |
10,336
-197,960
| -95% | -$15.6M |
|
663
Lithia Motors
LAD
$8.17B
| $868K | 0.01% |
7,308
-7,167
| -50% | -$793K |
|
664
Broadcom
AVGO
$1.72T
| $866K | 0.01% |
+30,090
| New | +$877K |
|
665
Global Payments
GPN
$25.1B
| $859K | 0.01% |
+5,367
| New | +$798K |
|
|
PPLI
666
People Inc
PPLI
$2.88B
| $858K | 0.01% |
22,063
-163,464
| -88% | -$6.52M |
|
667
National Beverage
FIZZ
$3.12B
| $857K | 0.01% |
38,406
+29,328
| +323% | +$754K |
|
|
TYPE
668
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $854K | 0.01% |
50,731
-16,683
| -25% | -$297K |
|
|
DOOR
669
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $850K | 0.01% |
16,144
+9,646
| +148% | +$499K |
|
670
Corcept Therapeutics
CORT
$13.2B
| $849K | 0.01% |
76,187
-39,642
| -34% | -$442K |
|
671
Oil States International
OIS
$501M
| $849K | 0.01% |
+46,397
| New | +$832K |
|
672
Tyler Technologies
TYL
$14.6B
| $849K | 0.01% |
3,930
-13,863
| -78% | -$3.01M |
|
|
VISN
673
Vistance Networks Inc
VISN
$2.53B
| $847K | 0.01% |
53,859
-560,858
| -91% | -$11.4M |
|
674
NewMarket
NEU
$8.63B
| $844K | 0.01% |
2,104
+1,048
| +99% | +$433K |
|
675
Gen Digital
GEN
$17.5B
| $839K | 0.01% |
+38,544
| New | +$829K |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.